Scholars Central

Review articlePublished 2019

Current Status from Mexican Medicinal Plants as Source of Antimycobacterial and Antituberculosis Compounds

Authors: Ma. Adelina Jiménez-Arellanes, Margarita L. Franco-García and Rosalba Léon-Díaz

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Tuberculosis (TB) is a worldwide health problem, being among the 10 causes of death by a single infectious agent. This infectionmainly impacts the economically active population, and it is aggravated by the presence of MDR and XDR strains. This scenario makesthe research for new alternatives of treatment imperative. Medicinal plants have proved to be a source of useful pharmaceutical moleculesfor lots of diseases, including TB. This manuscript is a review of the publications made from 2014 to date, focused on describing theantimycobacterial activity of extracts and pure compounds obtained from Mexican medicinal plants and their in vitro and in vivo activityagainst different strains of mycobacteria. The most active extracts against M. tuberculosis H37Rv were CH2Cl2, EtOAc and EtOH from Bidens odorata, and the EtOAc extractfrom Musa spp. The Hex extract from Trixis angustifolia (MIC=12.5 μg/mL) and the Hex and EtOAc extracts of Musa spp were activeagainst M. tuberculosis MDR (CIBIN 99) with MIC=12.5 and 6.25 μg/mL, respectively. From the EtOH extract of B. odorata, an activeglycoside against M. tuberculosis H37Rv (MIC=3.125 μg/mL) was isolated. Fractions 4 and 5 of T. angustifolia showed a MIC=12.5 and6.25 μg/mL against M. tuberculosis H37Rv and against M. tuberculosis R-INH and the INS-4 clinical isolate. To date, in vivo evaluationwith the pulmonary TB model in BALB/c mice of silymarin has been only reported. The compound reduced the bacillary load and lungpneumonia percentage. Extracts and/or pure bioactive compounds might improve and/or reduce the complex treatment scheme againstTB. Therefore, it is important that this type of research be carried out given the problem that TB represents.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Infectious Diseases & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Therapy
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Ma. Adelina Jiménez-Arellanes”
  • BylineArticles whose byline prints “Margarita L. Franco-García and Rosalba Léon-Díaz”